Loss of human epidermal receptor-2 in human epidermal receptor-2+ breast cancer after neoadjuvant treatment: A case report

BACKGROUND: Human epidermal receptor-2 (HER-2) expression has been reported to be discordant between primary tumor and metastatic tissue. CASE SUMMARY: We presented a case diagnosed with the HER-2+ breast cancer patient who exhibited changes in the expression of HER-2 receptors on tumour samples fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jing, Li, Nan-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258374/
https://www.ncbi.nlm.nih.gov/pubmed/35979138
http://dx.doi.org/10.12998/wjcc.v10.i17.5923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258374/
https://www.ncbi.nlm.nih.gov/pubmed/35979138
http://dx.doi.org/10.12998/wjcc.v10.i17.5923

Ejemplares similares